All About Mammograms: Section 2.a.
CONTENTS
2.1 Introduction: What is a Mammogram?
2.2 Screening Mammography
2.3 Special Populations and Breast Screening
2.3.1 Pregnant Women
2.3.2 Postmenopausal Women Taking Hormone Replacement Therapy (HRT)
2.3.3 Women with Breast Implants
2.3.4 Women with Prior Breast Biopsy or Surgery
2.3.5 Women with Post-Mastectomy Breast Reconstruction
2.3.6 Men
Forward to 2B on mammography. Back to 1C on Risk and breast density.
The diagnostic or investigational procedure that underpins the breast screening program worldwide is X-ray mammography.
Breast cancer screening programs using mammography also create clinical and research data.
But, if there are abnormalities on initial screening, additional testing, using other screening methods, may be necessary.
Also, there are remarkable refinements to further imaging techniques in recent years.
2.1 Introduction: What is a Mammogram?
When a woman first receives an invitation to attend for a routine screening mammogram, it can be a cause for concern.
If you have never had a mammogram, the questions are, what is a mammogram and what does it involve?
Furthermore, there is a lot of helpful information on the internet that can help prepare you for your mammogram. Check out our whole section on Breast Screening
Some patients may worry about the radiation dose from a routine screening mammogram. However, this dose is equivalent only to natural ‘background’ radiation over about three months.
Women who have BRCA1 or BRCA2 gene mutations may be at slightly greater risk for radiation-induced breast changes.
Figure 2.1
Diagram of the patient experience of mammography.
(Courtesy A.D.A.M. online image bank).
2.2 Screening Mammography
A mammogram is an X-ray image of the breast. Differences in breast tissue appear as different shades of grey on the image. Fat, being relatively radiolucent, permitting passage of the X-rays, appears as black on the film.
Tumors will appear as shades of grey while calcifications (micro-calcifications) are white.
Figure 2.2 Cranio-caudal (CC) Mammogram.
The normal breast.
(Courtesy of Yale.edu.imaging).
What is a Mammogram and Benign Breast Lesions
Benign breast lesions usually show, regular contours. Suspicious tumors, on the other hand, often appear as spiculated masses (needle-like shapes).
In addition, pleomorphic micro-calcifications, with or without a mass or lump, are likely to be mammographic cancers in 30% to 50% of cases.
On average, a mammogram will show around 85% of the breast content. So, up to 15% of breast tissue will not show on a mammogram.
Therefore, 15% of breast cancers may not show on the scan. However, it is possible to detect micro-calcifications on a mammogram that are typical of malignant tissue.
Mammogram Screening: What is a Mammogram?
Research shows that Screening mammography consistently decreases breast cancer-related deaths.
Routine evaluation of the breast involves obtaining two views, craniocaudal (CC) and mediolateral oblique (MLO) of each breast.
The density of the breasts is important too. an increase in breast density increases the risk of breast cancer. Furthermore, this can also decrease the ability of the mammogram to detect small lesions.
What is a Mammogram and Breast Implants
Women who have breast implants still need routine mammogram screening to evaluate any remaining breast tissue.
Women with breast implants who have no underlying breast tissue do not require regular mammograms.
The standard imaging technique in women with breast implants involves four views, rather than the usual two views per breast.
Mammograms can detect early-stage breast cancer.
This is the case even when there are no symptoms of breast cancer.
The United States surveillance data examined more than 1.8 million mammograms. These mammograms were taken between 2004 and 2008 on women between the ages of 18 years and 80 years.
The results show that mammography has a sensitivity of 84.4 % and a specificity of 90.8 %.
Furthermore, the recall rate was 9.6 %, and positive predictive value was 4.3 %. So this means that 4.3% of recall patients had a breast cancer diagnosis.
In 2014, a long-term, 25-year follow-up study raises the question of a possible decrease in the impact of screening mammography.
This is probably due to the fact that the treatment for breast cancer is more effective (Miller et al., 2014).
2.3 Special Populations and Breast Screening
There are certain groups who deserve special consideration for mammographic breast screening.
2.3.1 Pregnant Women
As a rule, specialists do not routinely perform mammograms in pregnant women.
Usually, doctors will perform a mammogram in pregnancy to diagnose and evaluate a suspected cancer. They may also check the other breast or assess findings that are not clear on ultrasound.
The breast undergoes physiological changes during pregnancy and lactation. Because of this, new breast disorders in pregnancy are usually benign and secondary to hormonal changes.
However, breast cancer in pregnancy represents up to 3 % of all breast cancers, and these tend to have a poorer prognosis.
The poorer prognosis of breast cancer in pregnancy is usually due to a delay in diagnosis because of difficulties in obtaining or interpreting mammograms.
In addition, clinical examinations can pose a problem too due to natural changes in the breasts in pregnancy.
The possible effect of radiation on the fetus means that mammography should be avoided during pregnancy.
The developing fetus is most susceptible to effects from radiation in the first few weeks of gestation.
In general, radiation doses of more than 5 rads or 50 mGy are harmful. A four view standard mammogram with abdominal shielding exposes the fetus to 0.4 rads or 4 mGy.
Breast imaging of a pregnant woman with a palpable breast abnormality begins with an ultrasound.
So mammography is only necessary if the ultrasound findings are suspicious for malignancy.
2.3.2 Postmenopausal Women Taking Hormone Replacement Therapy (HRT)
The normal changes of the breast tissue with age are inhibited by the use of hormone replacement therapy (HRT),
So, HRT increases breast density and may also decrease the sensitivity of mammography. The false-positive re-call rate may increase in post-menopausal women taking HRT.
2.3.3 Women with Breast Implants
Breast implants are huge, and not just literally. Indeed, statistics estimate that over two million women have breast implants in the U.S. alone.
Furthermore, the majority of breast implants consist of an envelope full of either silicone gel or saline.
Women with implants require routine screening mammograms to evaluate the leftover breast tissue.
Women with breast implants and no remaining breast tissue do not usually undergo routine mammography.
The presence of breast implants makes mammography very difficult. The implant contents are radiopaque, and this obscures small breast lesions.
In addition, the presence of the implant makes it difficult to evaluate all parts of the breast; it also makes compression difficult.
Standard imaging technique in women with breast implants involves four views, rather than the usual two views per breast.
Positioning is important to include as much breast tissue as possible by pushing the implant out of view. Usually, a Standard CC and MLO projection of each breast are necessary, both of which include the implant. Next, the implant is displaced back against the chest wall, with the breast tissue pulled forward and the two views are re-taken by mammogram.
More on Mammograms and Breast Implant Problems
Mammograms can also help to identify complications specific to the breast implants. One thing a mammogram can check is whether the implant is still intact.
Other common problems associated with implants are rupture of the implant capsule with or without leakage of contents and capsular contraction.
However, dedicated magnetic resonance is the imaging of choice for complications due to breast implants.
2.3.4 Women with Prior Breast Biopsy or Surgery
In the United States, around 1% to 2% of women have a breast biopsy following mammographic screenings. However, other countries have a much lower rate than this.
The effect of a prior breast biopsy on subsequent mammographic interpretation was investigated in a review of data from the Breast Cancer Surveillance Consortium. This study involved over 2 million mammograms in nearly 800,000 women (Taplin et al., 2010).
If a woman has a prior breast biopsy for a benign breast condition, this can reduce specificity for a breast cancer diagnosis in subsequent screening mammograms and biopsies.
Sometimes, this is because of the suspicious characteristics of the breast tissue and/or differing thresholds of mammogram interpretation for a prior biopsy.
2.3.5 Women with Post-Mastectomy Breast Reconstruction
Following a breast mastectomy, a mammogram is not routinely necessary. Because there is no breast tissue left, mammography provides no additional benefit in detecting recurrence.
Several methods of breast reconstruction are available following mastectomy. So, if silicone implants are present, MRI evaluation for breast implant issues is more sensitive than mammography.
Surgeons can also transfer tissue from other parts of the body, typically muscle to the skin, in reconstruction surgery.
A transverse rectus abdominis myo-cutaneous (TRAM) flap consists of muscle and fatty tissue from the abdominal wall that is moved up to the chest. This tissue has an intact blood supply to create the breast mound. Similar reconstruction can also be performed using the latissimus dorsi muscle.
More Breast Reconstructions and Mammograms
More commonly, surgeons construct a deep inferior epigastric perforator (DIEP) flap.
The flap consists of abdominal fat with its native blood supply.
Identifying breast cancer recurrences in the reconstructed flap is important as it has implications for future.
At present, a physical examination is a method of choice in monitoring myo-cutaneous breast reconstructions. However, it is difficult to identify lesions that are deep and can be difficult to distinguish a palpable area of fat necrosis from recurrent cancer.
Both mammography and ultrasound of a reconstructed breast are technically feasible. The mammographic appearance of recurrence is similar to that seen in a native breast.
Specific features on mammography can help distinguish recurrence from benign post-operative fat necrosis as a cause of a palpable breast lump
Ultrasound with fine-needle aspiration (FNA) or core biopsy has been shown to be valuable in identifying recurrence in both clinically palpable and occult lesions.
There is contradictory evidence regarding routine imaging of asymptomatic women with TRAM flap breast reconstruction.
2.3.6 Men
Although male breast cancer is uncommon, studies show the incidence rate is increasing (Giordano, 2004).
The American Cancer Society estimates that 2,190 men developed breast cancer in 2012 with 410 breast cancer deaths. This accounts for less than 1% of total breast cancer diagnoses. (Siegel, 2011).
Men do not undergo routine screening mammography.
Medics will refer men for imaging when clinical findings are present, such as a breast lump, breast thickening or pain.
The initial male mammogram includes standard bilateral CC and MLO views. Use of narrower paddles may facilitate compression, depending on breast size. Similar to women, additional mammographic views and ultrasound may be indicated to characterize any abnormalities and to facilitate biopsy if indicated.
Further Reading
- Full Index of ALL our Articles on Breast Cancer Screening
- All about Mammograms
- Mammogram Results: Callbacks and Followups
- Common Mammogram Findings
- Mammorgram shows breast Lump: What to do next
- Mammogram and Ultrasound Images Explained
Forward to 2B on mammography. Back to 1C on Risk and breast density.
Return to Homepage
Patient Information:
American Cancer Society. Breast Cancer Prevention and Early Detection: Mammograms. (Retrieved February 3rd 2015)
Centers for Disease Control and Prevention. What screening tests are there (Retrieved February 6th 2015): http://www.cancer.org/cancer/breastcancerinmen/detailedguide/breast-cancer-in-men-what-is-breast-cancer-in-men
References:
Miller, A.B., Wall, C., Baines, C.J., Sun, P., To, T., Narod, S.A. (2014). Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348, g366. (Retrieved October 29th 2014): https://www.ncbi.nlm.nih.gov/pubmed/24519768
Taplin, S.H., Abraham, L., Geller, B.M., Yankaskas, B.C., Buist, D.S., Smith-Bindman, R., Lehman, C., Weaver, D., Carney, P.A., Barlow, W.E. (2010). Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography. J Natl Cancer Inst. 102(14), 1040. (Retrieved October 28th 2014): https://www.ncbi.nlm.nih.gov/pubmed/20601590
.